Literature DB >> 9431322

Escherichia coli endocarditis of a native aortic valve.

D J Morrison1, L S Sperling, D A Schwartz, J M Felner.   

Abstract

The spectrum of organisms causing native valve endocarditis is changing. Despite an increasing incidence of infections caused by gram-negative organisms, they remain a rare cause of native valve endocarditis. Escherichia coli is especially uncommon. We describe the case of a 47-year-old man with no previous history of cardiac problems, who presented with culture-positive E coli endocarditis of his native aortic valve. His complicated clinical course necessitated emergent valve replacement, emphasizing the virulence of this organism. The high mortality rate and significant morbidity associated with this entity necessitates aggressive medical management and early surgical intervention.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9431322

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  4 in total

1.  The bacterial adaptive response gene, barA, encodes a novel conserved histidine kinase regulatory switch for adaptation and modulation of metabolism in Escherichia coli.

Authors:  Surasri Nandan Sahu; Sharmistha Acharya; Helina Tuminaro; Isha Patel; Kim Dudley; J Eugene LeClerc; Thomas A Cebula; Suman Mukhopadhyay
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

2.  Diagnosis of E. coli tricuspid valve endocarditis: a case report.

Authors:  Takahiko Tsutsumi; Eiji Hiraoka; Kenji Kanazawa; Hozuka Akita; Lawrence J Eron
Journal:  Hawaii Med J       Date:  2010-12

Review 3.  Escherichia coli endocarditis: seven new cases in adults and review of the literature.

Authors:  S Branger; J P Casalta; G Habib; F Collard; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

Review 4.  Native valve endocarditis due to Escherichia coli infection: a case report and review of the literature.

Authors:  Nobuhiro Akuzawa; Masahiko Kurabayashi
Journal:  BMC Cardiovasc Disord       Date:  2018-10-19       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.